Decreased somatostatin is related to the hypersensitivity of intestinal epithelia to LPS via upregulated TLR4-TBK1 pathway in rats chronically exposed to ethanol

Alcohol

Volumn 43, Issue 4, 2009, Pages 293-303

  Zhou, Chao ^a   Li, Jing ^a   Wang, Haiying ^a   Tang, Chengwei ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Ethanol; Intestinal epithelium; Lipopolysaccharide; Somatostatin; TANK binding kinase 1; Toll like receptor 4

Indexed keywords

ALCOHOL; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PHOSPHOTRANSFERASE; SOMATOSTATIN; TANK BINDING KINASE 1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WATER;

ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; ENTERITIS; ESCHERICHIA COLI; HISTOPATHOLOGY; IN VITRO STUDY; INTESTINE EPITHELIUM; INTESTINE FLORA; INTESTINE MUCOSA; LACTOBACILLUS; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SOMATOSTATIN BLOOD LEVEL; SOMATOSTATIN RELEASE; UPREGULATION; WISTAR RAT;

ANIMALS; ETHANOL; INTESTINAL MUCOSA; LIPOPOLYSACCHARIDES; MALE; PROTEIN-SERINE-THREONINE KINASES; RANDOM ALLOCATION; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; SOMATOSTATIN; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

ESCHERICHIA COLI; RATTUS; RATTUS NORVEGICUS;

EID: 67649121817     PISSN: 07418329     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.alcohol.2009.03.002     Document Type: Article

References (25)

1. Baraona E., Julkunen R., Tannenbaum L., and Lieber C.S. Role of intestinal bacterial overgrowth in ethanol production and metabolism in rats. Gastroenterology 90 (1986) 103-110
2. Bone R.C. Immunologic dissonance: a continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann. Intern. Med. 125 (1996) 680-687
3. Cook R.T., Schlueter A.J., Coleman R.A., Tygrett L., Ballas Z.K., Jerrells T.R., et al. Thymocytes, pre-B cells, and organ changes in a mouse model of chronic ethanol ingestion-absence of subset-specific glucocorticoid-induced immune cell loss. Alcohol. Clin. Exp. Res. 31 (2007) 1746-1758
4. Elmer G.W., Surawicz C.M., and McFarland L.V. Biotherapeutic agents. A neglected modality for the treatment and prevention of selected intestinal and vaginal infections. JAMA 275 (1996) 870-876
5. Esper A., Burnham E.L., and Moss M. The effect of alcohol abuse on ARDS and multiple organ dysfunction. Minerva. Anestesiol. 72 (2006) 375-381
6. Feng C.G., Scanga C.A., Collazo-Custodio C.M., Cheever A.W., Hieny S., Caspar P., et al. Mice lacking myeloid differentiation factor 88 display profound defects in host resistance and immune responses to Mycobacterium avium infection not exhibited by Toll-like receptor 2 (TLR2)- and TLR4-deficient animals. J. Immunol. 171 (2003) 4758-4764
7. Fry D.E. Mast cells. In: Baue A.E., Faist E., and Fry D.E. (Eds). Multiple organ failure (2000), Springer-Verlag Press, New York 188-195
8. Gohda J., Matsumura T., and Inoue J. Cutting edge: TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not Toll/IL-1 receptor domain-containing adaptor-inducing IFN-β (TRIF)-dependent pathway in TLR signaling. J. Immunol. 173 (2004) 2913-2917
9. Grotz M.R., Deitch E.A., Ding J., Xu D., Huang Q., and Regel G. Intestinal cytokine response after gut ischemia: role of gut barrier failure. Ann. Surg. 229 (1999) 478-486
10. Hauge T., Persson J., and Danielsson D. Mucosal bacterial growth in the upper gastrointestinal tract in alcoholics (heavy drinkers). Digestion 58 (1997) 591-595
11. Kobayashi R., Okamura S., Ohno T., Saito H., Mori M., Ra C., et al. Hyperexpression of FcgammaRI and Toll-like receptor 4 in the intestinal mast cells of Crohn's disease patients. Clin. Immunol. 125 (2007) 149-158
12. Michelsen K.S., and Arditi M. Toll-like receptors and innate immunity in gut homeostasis and pathology. Curr. Opin. Hematol. 14 (2007) 48-54
13. Moss M., Parsons P.E., Steinberg K.P., Hudson L.D., Guidot D.M., Burnham E.L., et al. Chronic alcohol abuse is associated with an increased incidence of acute respiratory distress syndrome and severity of multiple organs dysfunction in patients with septic shock. Crit. Care Med. 31 (2003) 869-877
14. Nieuwenhuijzen G.A., and Goris R.J. The gut: the "motor" of multiple organ dysfunction syndrome?. Curr. Opin. Clin. Nutr. Metab. Care 2 (1999) 399-404
15. Nosova T., Jokelainen K., Kaihovaara P., Jousimies-Somer H., Siitonen A., Heine R., et al. Aldehyde dehydrogenase activity and acetate production by aerobic bacteria representing the normal flora of human large intestine. Alcohol Alcohol. 31 (1996) 555-564
16. Pruett S.B., Schwab C., Zheng Q., and Fan R. Suppression of innate immunity by acute ethanol administration: a global perspective and a new mechanism beginning with inhibition of signaling through TLR3. J. Immunol. 173 (2004) 2715-2724
17. Rangel-Frausto M.S., Pittet D., Costigan M., Hwang T., Davis C.S., and Wenzel R.P. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273 (1995) 117-123
18. Reisine T., and Bell G. Molecular biology of somatostatin receptors. Endocr. Rev. 16 (1995) 427-442
19. Sato S., Sugiyama M., Yamamoto M., Watanabe Y., Kawai T., Takeda K., et al. Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the Toll-like receptor signaling. J. Immunol. 171 (2003) 4304-4310
20. Swank G.M., and Deitch E.A. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J. Surg. 20 (1996) 411-417
21. Tang C., Lan C., Wang C., and Liu R. Amelioration of the development of multiple organ dysfunction syndrome by somatostatin via suppression of intestinal mucosal mast cells. Shock 23 (2005) 470-475
22. Trayhurn P., Bing C., and Wood I.S. Adipose tissue and adipokines-energy regulation from the human perspective. J. Nutr. 136 (2006) 1935S-1939S
23. Umesaki Y., Okada Y., Imaoka A., Setoyama H., and Matsumoto S. Interactions between epithelial cells and bacteria, normal and pathogenic. Science 276 (1997) 964-965
24. Volman T.J., Hendriks T., Verhofstad A.A., Kullberg B.J., and Goris R.J. Improved survival of TNF-deficient mice during the zymosan-induced multiple organ dysfunction syndrome. Shock 17 (2002) 468-472
25. Wisse B.E. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J. Am. Soc. Nephrol. 15 (2004) 2792-2800